Saturday, 14 December 2019

Australia News

  • US, EU, Aussie and Canada together churn $98.8 bn biotech revenue in 2013: EY

    Australia |  Analysis | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Global biotechnology industry rebounded strongly in 2013, with public companies achieving double-digit revenue growth and a sharp increase in funds raised, according to Ernst &am...Read more

  • Pharmaxis gets grants for fibrotic research

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jul, 2013

    Singapore: Australian pharmaceutical company Pharmaxis' research projects conducted in conjunction with the University of Sydney have been awarded funding under the Australian Research Coun...Read more

  • Book Doctor's appointment through an app

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: In a bid to provide easier access to primary healthcare services, CQ medicare local has secured funding for the online service provider directory and booking system. The CQ heal...Read more

  • Clinical Network Services acquires Beltas' assets

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jan, 2013

    Singapore: Clinical Network Services (CNS), an Australia-based CRO offering integrated development services in the planning, implementation and delivery of phase I and II trials, has acquir...Read more

  • Clinical Network Services acquires BELTAS' business assets

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Australian CRO, Clinical Network Services (CNS), has acquired the business assets of its erstwhile New Zealand partner BELTAS, a CRO based in Auckland. Terms of the deal were not...Read more

  • Mesoblast to set up stem cell drug plant in Singapore

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 29 May, 2014

    Singapore: Australian regenerative drug company, Mesoblast, is planning to expand its global manufacturing base and the company is in dialogues with Singapore Economic Development Board (ED...Read more

  • Phylogica extends collaboration with Janssen Biotech

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jan, 2013

    Singapore: Phylogica, a leading Australian peptide drug discovery company, has extended its collaboration with Janssen Biotech and its affiliates to discover, develop and commercialize new ...Read more

  • Novartis MenB vaccine gets approval in Australia

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 15 Aug, 2013

    Singapore: Australian Therapeutic Goods Administration (TGA) has approved Novartis' Bexsero, a multi-component Meningococcal B (MenB) vaccine (recombinant, adsorbed) suspension for injectio...Read more

  • Chickungunya can soon be prevented with a vaccine

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jun, 2014

    Singapore: Australian biotech firm, Themis Bioscience GmbH declared the successful interim results of their prophylactic vaccine candidate against Chikungunya fever on June 12, 2014. The ex...Read more

  • Universal gets $250k tech implementation vouchers

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 15 Apr, 2013

    Singapore: Universal Biosensors, developer of cardiac marker biosensor, is one-of-the-seven firms to receive Technology Implementation Vouchers totalling $250,000. Mr Gordon Rich-Phillips,...Read more

  • Who will wear the CSL mantle?

    Australia |  Influencers | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2012

    Singapore: Current president of CSL Behring, Mr Paul Perreault, will be the new CEO of the firm after Dr Brian McNamee steps down in July 2013. Dr Brian McNamee will leave CSL in July 2013 ...Read more

  • Cell pics by GE contest winners to light up Times Square

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 28 Feb, 2013

    Singapore: GE Healthcare Life Sciences has chosen Ms Jane Stout (from the US), Ms Anushree Balachandran (from Australia) and Mr Markus Posch (from the UK) as winners of the GE Healthcare 20...Read more

  • Viralytics accelerates patient recruitment for Cavatak trial

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 21 Mar, 2013

    Singapore: Patient recruitment in phase II CALM trial has accelerated significantly in the past three months with 25 patients now enrolled. Viralytics, which is conducting the trial, said ...Read more

  • OECD: Australia has 527 biotech firms, ranks 6th

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jan, 2013

    Singapore: According to the Organisation for Economic Co-operation and Development's (OECD) directorate for Science, Technology and Industry statistics (updated until December 2011), Austra...Read more

  • Dr John Ballard: Angel of Australia biotech

    Australia |  Influencers | By BioSpectrum Bureau  | 0 Comment | 13 Mar, 2012

    Veterans in the life sciences industry in Australia distinguish Dr John Ballard as one of the founding and most significant leaders of the country's biotechnology industry. He is co-founder...Read more

  • AtCor Medical wins $3.2 mn contract

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 08 Oct, 2012

    Singapore: AtCor Medical, developer and marketer of the SphygmoCor system which measures central aortic blood pressures and arterial stiffness non-invasively, has signed a contract to suppl...Read more

  • BioSA awards for Aussie innovators

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 28 Mar, 2013

    Singapore: BioSA revealed that names of the awardees of the BioSA Bioscience Achievement Awards at its Welcome Reception for the AusBiotech Business Development Forum, held in Glenelg, Adel...Read more

  • iSonea updates its AsthmaSense app

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 07 Dec, 2012

    Singapore: Medical technology company iSonea has unveiled an updated version of its AsthmaSense asthma management smartphone app at a US mobile health conference. The updated version is e...Read more



Podcast

 

Survey Box

Is APAC region emerging as a leader in assistive technologies?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls